Amarin Corporation

Amarin Corporation EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Amarin Corporation (AMRN) as of Oct 18, 2026 is -13.94 M USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -91.80 M USD — a change of -84.81% (higher).

EBITDA

-13.94 MUSD

YoY

-84.81%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Amarin Corporation is 2025 -13.94 M USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Amarin Corporation was 2024 -91.80 M USD. It decreases by -84.81% higher compared to the previous year.

The Amarin Corporation EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
-107.85 M USD
Jan 1, 2019
-24.28 M USD
Jan 1, 2020
-19.66 M USD
Jan 1, 2021
10.50 M USD
Jan 1, 2022
-105.87 M USD
Jan 1, 2023
-56.62 M USD
Jan 1, 2024
-91.80 M USD
Jan 1, 2025
-13.94 M USD
The Amarin Corporation EBITDA history
YEAREBITDAYoY
-13.94 MUSD-84.81%
-91.80 MUSD+62.14%
-56.62 MUSD-46.52%
-105.87 MUSD-1,108.08%
10.50 MUSD-153.43%
-19.66 MUSD-19.05%
-24.28 MUSD-77.49%
-107.85 MUSD+134.11%
-46.07 MUSD-20.49%
-57.94 MUSD-41.01%
-98.22 MUSD+2.36%
-95.96 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Amarin Corporation Stock analysis

What does Amarin Corporation do? Amarin Corporation PLC, based in Dublin, Ireland, operates in the Health Care sector within the Biotechnology industry. The company focuses on developing and commercializing therapeutics for cardiovascular health, with its lead product Vascepa (icosapent ethyl) approved by the FDA for reducing triglyceride levels in patients with severe hypertriglyceridemia. Vascepa is distributed through wholesalers, regional distributors, and specialty pharmacies to retail pharmacies for patient access. Amarin Corporation is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Amarin Corporation stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Amarin Corporation is -13.94 M USD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Amarin Corporation changed from -91.80 M USD to -13.94 M USD, representing a -84.81% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Amarin Corporation since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Amarin Corporation historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Amarin Corporation

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Amarin Corporation